Miner Lab
@miner_lab
Mechanisms & therapies for rare rheumatic diseases. Chair, Gene Therapy and Vaccines (GTV) Graduate Program @CAMBUPenn @UPenn_I3H @pennmedicine @rvcl_research
ID: 1202748585370095616
https://www.med.upenn.edu/minerlab 06-12-2019 00:36:39
550 Tweet
2,2K Followers
2,2K Following
Join Penn Medicine - Abramson Cancer Center & CHOP Research April 30th-May 2nd for Cellicon Valley '25: The Future of Cell & Gene Therapies! Learn more & register➡️ med.upenn.edu/cellicon25/
New research led by Jake Brenner unlocks safe DNA-loaded lipid nanoparticles for #GeneTherapy, using a natural molecule to stop deadly immune reactions, which could transform treatment for chronic diseases. spr.ly/6015FBOQU
New research out in Molecular Cell finds that PARP2 active site helix melts to permit DNA damage-induced enzymatic activation ft. Emily Smith-Pillet, Ramya Billur & Ben Black (UPenn Dept of Biochem & Biophys) Penn Center for Genome Integrity Penn Epigenetics BBCB Graduate Group sciencedirect.com/science/articl…
Treating the untreatable - "Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure" Penn Medicine @nejm #immunotherapy nejm.org/doi/full/10.10…
An incredible feat...making a personalized, clinical-grade CRISPR gene therapy in 6 months that is actually efficacious! As Fyodor Urnov put it, this "is a triumph for the American peoples’ investment in biomedical research" nytimes.com/2025/05/15/hea…
Co-first authorship for Sarah Grandinette (Sarah Grandinette) in the Kiran Musunuru lab on: Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease | New England Journal of Medicine (NEJM) nejm.org/doi/full/10.10…
ATG9A vesicles play a crucial autophagy-independent role in galectin-9 secretion, unveiling a unique pathway separate from classical and secretory autophagy mechanisms. PMID:40335523, Nat Commun 2025, Nature Communications doi.org/10.1038/s41467… #AI #Pharma #BioMed #RNA #ASHG #ESHG